Company / R&D per Share
Arcturus Therapeutics Holdings Inc. R&D per Share History
FY2019-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest R&D per Share
$4.16
FY2025
5-year range
$4.16 / $7.27
FY2021-FY2025
Trend
-42.9%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
R&D per Share has fluctuated over the past 7 years, ranging from $1.12 in FY2020 to $7.27 in FY2024.
Based on SEC 10-K filings.
4.16 in FY2025 with a 5-year CAGR of +29.9%.
Declined from $7.24 to $4.16 over the past 2 years.
R&D per Share over time
Growth rates
- 3-Year CAGR
- -14.2%
- 5-Year CAGR
- +29.9%
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, r&d per share decreased 42.9% year-over-year.
- Peak r&d per share was recorded in FY2024.
- Lowest r&d per share in the period was in FY2020.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score -0.06 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | R&D per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $4.16 | -42.9% |
| FY2024 | $7.27 | +0.5% |
| FY2023 | $7.24 | +9.8% |
| FY2022 | $6.59 | -0.7% |
| FY2021 | $6.63 | +491.4% |
| FY2020 | $1.12 | -29.2% |
| FY2019 | $1.58 | - |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026